EFFICIENCY OF LOW-FREQUENCY MAGNETIC THERAPY IN THE COMBINATION TREATMENT OF CHRONIC LOW BACK PAIN IN THE PRESENCE OF LUMBAR OSTEOCHONDROSIS

The low back pain is defined as pain or discomfort in an area around the upper portion of T12 and bottom of the gluteal fold, with functional limitation. It is the second most frequent cause of medical consultation at first care level. Objective: propose a protocol through electrotherapy utilizing transcutaneous electrical nerve stimulation (TENS) for the treatment of nonspecific chronic low back pain; It seeks to exemplify in a clear and concise method the type of frequency, pulse duration, intensity, placement of the electrodes, as well as duration and periodicity of the sessions to obtain the desired analgesic effect. Methodology: Quantitative type, non-experimental, retrospective, transversal and descriptive. Contribution: The application of Transcutaneous Electrical Nerve Stimulation in high and low frequency in the same session is effective in the treatment of nonspecific chronic low back pain because the lumbar mobility increases, the intensity of the pain decreases and therefore the degree of disability of patients.

Download Full-text

Effects of pulsed low-frequency magnetic field therapy on pain intensity in patients with musculoskeletal chronic low back pain: study protocol for a randomised double-blind placebo-controlled trial

BMJ Open ◽

10.1136/bmjopen-2018-024650 ◽

2019 ◽

Vol 9 (6) ◽

pp. e024650 ◽

Cited By ~ 1

Author(s):

Fuad A Abdulla ◽

Saad Alsaadi ◽

MIR Sadat-Ali ◽

Fahd Alkhamis ◽

Hani Alkawaja ◽

...

Keyword(s):

Magnetic Field ◽

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Short Form ◽

Low Frequency ◽

Treatment Completion ◽

Patient Specific ◽

Low Back ◽

Frequency Magnetic Field

IntroductionThe aim of the present study is to investigate the effectiveness of pulsed low-frequency magnetic field (PLFMF) on the management of chronic low back pain (CLBP).Methods and analysisA randomised double-blinded controlled clinical trial will be conducted, involving 200 patients with CLBP. Participants will be randomised in a 1:1 ratio to receive either active PLFMF (experimental arm) or sham treatment (control arm) using a permuted-block design which will be stratified according to three subtypes of musculoskeletal CLBP (nociceptive, peripheral neuropathic or central sanitisation). The intervention consists of three sessions/week for 6 weeks. The primary outcome is the percentage change in Numerical Rating Scale (NRS) pain at week 24 after treatment completion with respect to the baseline. Secondary outcomes include percentage NRS pain during treatment and early after treatment completion, short form 36 quality of life, Roland and Morris Disability Questionnaire; Depression Anxiety Stress Scale 21, Patient Specific Functional Scale, Global perceived effect of condition change, Pittsburgh Sleep Quality Index and Modified Fatigue Impact Scale. Measures will be taken at baseline, 3 and 6 weeks during the intervention and 6, 12 and 24 weeks after completing the intervention. Adverse events between arms will be evaluated. Data will be analysed on an intention-to-treat basis.Ethics and disseminationThe study is funded by Imam Abdulrahman Bin Faisal University (IAU). It has been approved by the institutional review board of IAU (IRB‐ 2017‐03–129). The study will be conducted at King Fahd Hospital of the University and will be monitored by the Hospital monitoring office for research and research ethics. The trial is scheduled to begin in September 2018. Results obtained will be presented in international conferences and will be published in peer-reviewed journals.Trial registration numberACTRN12618000921280, prospectively.

Download Full-text